Meanwell and Maraganore get $80M for cardio prevention biotech Corseranews2026-01-07T11:00:31+00:00January 7th, 2026|Endpoints News|
Cancer biotech Disco lines up Amgen as first pharma partnernews2026-01-07T10:00:58+00:00January 7th, 2026|Endpoints News|
Mediar Therapeutics gains $76M to get three fibrosis drugs to key clinical datanews2026-01-06T12:00:20+00:00January 6th, 2026|Endpoints News|
Aktis Oncology eyes $181M listing to start industry’s anticipated IPO reboundnews2026-01-05T12:11:50+00:00January 5th, 2026|Endpoints News|
Comanche gets $40M more to test its preeclampsia siRNAnews2026-01-05T11:30:31+00:00January 5th, 2026|Endpoints News|
Biotech’s groove is back for 2026 as XBI surges on M&A and lower ratesnews2025-12-30T16:27:21+00:00December 30th, 2025|Endpoints News|
Nido Bio to wind down after underwhelming Phase 2 datanews2025-12-29T17:23:00+00:00December 29th, 2025|Endpoints News|
Windward gets bispecific from Qyuns in its second China deal of the yearnews2025-12-22T15:46:03+00:00December 22nd, 2025|Endpoints News|
Boehringer taps Rectify to create pills for chronic kidney diseasenews2025-12-22T13:00:04+00:00December 22nd, 2025|Endpoints News|
Aktis Oncology files for IPO to fund Lilly-partnered radiopharma pipelinenews2025-12-22T10:45:45+00:00December 22nd, 2025|Endpoints News|
